Novel Therapies for Type 1 Diabetes
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
How has Type 1 diabetes evolved in our society? When does the disease strike, and can we take preemptive action before it does? Dr. Ron Wilder, an internationally recognized rheumatologist and immunologist, speaks with host Dr. Danny Petrasek, addressing our ability to interfere with the disease physiology.
Overview
How has Type 1 diabetes evolved in our society? When does the disease strike, and can we take preemptive action before it does? Dr. Ron Wilder, an internationally recognized rheumatologist and immunologist, speaks with host Dr. Danny Petrasek, addressing our ability to interfere with the disease physiology.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
FCS and SHTG: Are We Meeting the Need?
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?